Strange Bedfellows –
September 6, 2019 – Eleanor Health is rethinking how to treat addiction—now the leading cause of death in America for those under aged 50 years—by fully treating addiction as a chronic disease. Eleanor Health will focus on clinical and non-clinical factors to manage the disease and provide both human and high-tech support. This includes comprehensive treatment, including medication-assisted treatment (MAT) for opioid and other substance use disorders. The Eleanor Health approach is designed to meet patients where they are in their recovery journey, through outpatient clinics, community settings, and at home through technology and field-based teams, the company states. It is designed to be financially accountable for long-term, whole-person outcomes.
“We launched Eleanor Health to help people with addiction challenges live amazing lives by providing evidence-based, whole-person treatment for substance use disorders and mental health. We are committed to treating these conditions as chronic medical illnesses requiring long-term management, and to being reimbursed based on positive health outcomes,” says Eleanor Health CEO and co-founder Corbin Petro. “We are leveraging data and new technology to enhance in-person clinical service delivery and building a world-class team committed to our mission and vision.”
